Tricor (fenofibrate) for patients with high triglycerides (TGs)

May 1998

Abbott is now marketing Tricor (fenofibrate) for patients withhigh triglycerides (TGs). This drug is widely used in Europe.

Tricor is in the same class as Lopid (gemfibrozil).

It's an alternative to using Lopid or niacin...to lowertriglycerides and increase HDL. Tricor also helps lower totalcholesterol, but not as well as the statins.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

tamoxifen (Nolvadex) to PREVENT breast cancer
Renal & Urology new impotence drug, Viagra (sildenafil)
Renal & Urology Detrol (tolterodine) for urinary frequency, urgency, or urge incontinence
Cardiology whether more patients with heart failure should get warfarin
Cardiology Ticlid seems to increase the risk of another potentially fatal blood disorder
Diabetes Prandin (repaglinide), a new oral hypoglycemic for type 2 diabetes
recommending vitamin and mineral supplements
Lice unusual head lice treatments
Cholesterol Pravachol (pravastatin) and Zocor (simvastatin) are now approved to prevent STROKE
Cholesterol liver function tests can be done less frequently for patients taking statins
Cholesterol Tricor (fenofibrate) for patients with high triglycerides (TGs)
Ophthalmology several new prescription eye drops for allergies and inflammation
Parkinson's Disease changes in the treatment of Parkinson's
attention on adverse drug reactions
Cardiology higher doses of ACE inhibitors

Tricor (fenofibrate) for patients with high triglycerides (TGs)

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents